SMS Pharmaceuticals Limited (SMSPHARMA) — Announcement | 1 July 2026

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

SMS Pharmaceuticals clarified that the recent spike in trading volume is purely market-driven and not linked to any undisclosed material information, reaffirming full compliance with SEBI disclosure norms and confirming no new operational developments.

📄 View Original Announcement (PDF)

About SMS Pharmaceuticals Limited (SMSPHARMA)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹3,493.69 Cr P/E: 33.2 ROE: 14.3% ROCE: 15.2% Div Yield: 0.11%

View full SMSPHARMA stock details →

📡 Get AI alerts when SMSPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SMSPHARMA — Free

📊 More SMSPHARMA filings

See all SMSPHARMA filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SMSPHARMA files new disclosures

Track SMSPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track SMSPHARMA — Free

Free account · 2 AI queries/day